Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market
Eli Lilly shares rose 4% on Monday, driven by compelling new data for its next-generation obesity drug, retatrutide, with analysts and investors expecting it to extend the
June 08, 2026
Hong Kong charges 7 people and 2 firms over deadly fire that killed 168
Aftershocks complicate Philippine recovery from quake that killed 45 and displaced thousands
China Inc deploys 'quiet' layoffs as Beijing promotes AI adoption
Celebrations clash with social tensions in Mexico ahead of World Cup
German retailers expect only modest boost from World Cup